Our research

Oral Lisdexamfetamine for the treatment of Acute Methamphetamine withdrawal (the OLAM trial): A randomised controlled trial

An Open-Label Safety and Feasibility Pilot Trial of Oral Naltrexone-Bupropion Combination Pharmacotherapy for Methamphetamine Use Disorder

An open-label, safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder

A double-blind randomised controlled trial to evaluate the efficacy of lisdexamfetamine in reducing methamphetamine use

A qualitative study exploring diverse cultures, practices and experiences of GHB use among LGBTQ Australians

The Substance Use and Sex Index (SUSI) addresses a lack of tools for measuring transmission-risk behaviours alongside HIV treatment and prevention innovations, and the context of drug use such as “chemsex” and “party and play”.